NHS drugs can change people’s lives with difficulties in diagnosing and treating people’s lives.
The new pills designed to transform the weak ‘invisible’ conditions are approved to be used in NHS.
Approved by the National Institute for Health and Care Excellence (NIC), the drug can help 1,000 women in the UK to live with endometriosis.
According to Nice, the painful chronic state affects about 1.5 million women in the UK. Occurs when abnormal tissues grow outside the uterine lining and spread to other parts of the body, such as pelvis, bladder and intestines.
Unlike the current injectable treatment, new drugs can be taken at home and work faster. Daily long -term pills can block certain hormones and significantly reduce severe bleeding, which can relieve invisible symptoms caused by endometriosis such as severe pain and severe periods.
The NICE first rejected a drug called Relugolix-ESTRADIOL-NORETHISTERONE or RYEEQO with a list price of £ 72 for the 28th supply. But the new evidence provided by manufacturer Gedeon Richter has been approved by NHS.
Helen Knight, director of NICE’s pharmaceutical evaluation, said: “This new treatment shows potential changes in how we manage endometriosis, and returns control of the patient’s hands while ensuring the value of taxpayers.
“Instead of traveling with a clinic for injections, there is a daily tablet that can be taken at home. Treatment can also stop and start more easily, which is especially important for planning children and managing side effects. This convenience not only helps patients, but also reduces pressure on NHS services. ”
RYEQO has already been approved for use in endometriosis in Australia and can also be used to treat prostate cancer. According to European medical institutions, the level of a particular hormone is lowered to encourage the release of other hormones, which helps to relieve symptoms and prevent the womb’s prevalent organization growth.
On average, NICE says that it takes nine years to begin to diagnose endometriosis. According to the NHS website, symptoms can be similar to other common conditions such as fibroids, pelvic inflammatory diseases and irritable bowel syndrome.
